儿科罕见病治疗开发的创新和最佳实践:以模型为基础的药物开发视角
Rajesh Krishna1, Satyendra Suryawanshi2, Juliane Rascher3
1Certara Drug Development Solutions, Certara USA, Inc., Radnor, Pennsylvania, USA.
Clinical pharmacology and therapeutics
|April 16, 2025
概括
基于模型的药物开发 (MIDD) 通过实现高效,数据驱动的决策来增强儿科罕见病的治疗开发. 这种方法优化了试验,并为患有罕见疾病的儿童提供了个性化治疗.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 罕见疾病 罕见疾病
- 儿科医学 儿科医学
背景情况:
- 儿科罕见病药物开发面临挑战,原因是患者人群较小,异质,治疗选择有限.
- 现有的挑战加剧了成人和儿科疾病表现之间的差异.
- 监管指南 (ICH E11 (R1)) 强调建模和模拟,以解决知识差距和不确定性.
研究的目的:
- 批判性地研究基于模型的药物开发 (MIDD) 在推进儿科罕见病治疗策略中的作用.
- 探索生物标志物的整合,统计创新和建模和模拟的最佳实践.
- 突出数字生物标志物,患者报告的结果和生活质量指标的潜力.
主要方法:
- 对儿科罕见病中MIDD的现有文献和监管指导的审查和分析.
- 检查模拟和模拟技术用于推断和决策的应用.
- 讨论整合新的数据来源,如数字生物标志物和患者报告的结果.
主要成果:
- 在儿科罕见病药物开发中,MIDD为高效,数据驱动的决策提供了强大的解决方案.
- MIDD促进了将成年人治疗反应推断到儿科患者群体,有助于目标活力和剂量选择.
- 集成先进的方法可以减少对大型,昂贵的试验的需求,同时确保相关的临床终点.
结论:
- MIDD对于克服儿科罕见病治疗开发的挑战至关重要.
- 整合数字生物标志物,患者报告的结果和生活质量方法将推动个性化,以患者为中心的护理.
- 这些进步有望向更有效,更为适合这一脆弱群体的治疗方法显著转变.
相关概念视频
Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Drug Administration and Therapy Phases: Overview
386
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
386
Prescription, Nonprescription and Orphan Drugs
658
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
658
EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K


